What is Embody GLP-1?
Embody GLP-1 is a fully virtual telehealth platform offering compounded semaglutide and tirzepatide with a standout format: oral tirzepatide in chewable gum form.
One of very few platforms in the space offering a non-injectable tirzepatide option, which is a genuine clinical differentiator for needle-phobic patients or those who find injection administration difficult. 350,000+ patients served. Featured in Forbes, Bloomberg, NYT, and Healthline. HSA/FSA eligible. No long-term contract — cancel anytime. 24/7 specialist support included.
Tirzepatide is a dual GIP/GLP-1 receptor agonist. For regulatory context on compounded tirzepatide, see the FDA's compounding guidelines.
Embody GLP-1 pricing — what you’ll actually pay
The $149 first-month price is a promotional entry point — not the ongoing rate. Standard refills are $299/mo. At $299/mo ongoing, Embody GLP-1 is $50–$120/mo above most comparable programs. Calculate your 12-month total cost at $299/mo therapeutic dose before enrolling.
| Item | Price | Notes |
|---|---|---|
| First month (all-in) | $149 | Includes physician review, metabolic report, 1:1 guidance, medication |
| Standard refill | $299/mo | Ongoing rate — confirm this is your long-term cost |
| Oral tirzepatide gum | Included | One of the only platforms with this format |
| Injectable option | Included | Both injectable and gum formats available |
| 24/7 support | Included | Specialist support access |
| HSA/FSA | Eligible | Confirm with your card administrator |
How Embody GLP-1 works
- Physician review: Licensed physician reviews your intake form and medical history.
- Metabolic report: Personalized metabolic report included in your first month.
- 1:1 guidance: One-on-one guidance session included in month one.
- Medication shipment: Oral tirzepatide gum or injectable semaglutide/tirzepatide shipped to your door.
- 24/7 support: Specialist support accessible around the clock throughout treatment.
Pros and cons — the honest assessment
What we like
- Oral tirzepatide gum — rare, genuinely useful for needle-phobic patients
- Personalized metabolic report included in first month
- 1:1 guidance session included
- $149 first month — low-risk entry point
- 350,000+ patients — major operational scale
- Featured in Forbes, Bloomberg, NYT — significant media validation
- HSA/FSA eligible
- 24/7 specialist support included
- No long-term contract
Watch out for
- $299/mo refill price — above most competitors by $50–$120/mo
- $149 is promotional first-month pricing — not the long-term rate
- Calculate 12-month total at $299/mo before deciding
- Compounded medications only — no brand-name Wegovy or Zepbound
- Limited company transparency on founding team and headquarters
- Compounded medications are not FDA-approved finished products
The $149 first month makes Embody GLP-1 appealing as a low-risk entry point. But at $299/mo for standard refills, the 12-month total (month 1 + 11 refills) is $149 + $3,289 = $3,438. Compare this against comparable programs at $199–$249/mo before committing long-term.
Who Embody GLP-1 is right for
Embody GLP-1 is the right choice for patients who specifically need a non-injectable tirzepatide option.
The chewable gum format is genuinely rare — if needles are the barrier to starting treatment, Embody GLP-1 removes it for tirzepatide in a way few other programs do. For patients without needle aversion, the $299/mo ongoing price point makes it harder to justify compared to programs at $199–$249/mo. Run the 12-month math at your likely therapeutic dose before committing.
Bottom line
Embody GLP-1 is a well-established platform with a unique differentiator: oral tirzepatide gum.
For the right patient — needle-phobic, wanting tirzepatide specifically — it's a compelling option. For everyone else, the $299/mo ongoing rate is above market average and worth comparing against programs that offer similar support at lower long-term cost. Take advantage of the $149 first month to evaluate if the format works for you.
Medical disclaimer: This review is for informational purposes only and does not constitute medical advice. GLP-1 medications are prescription-only and require evaluation by a licensed healthcare provider. Compounded medications are not FDA-approved finished products. Individual results vary. Consult your physician before beginning any weight loss medication program.